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Evidence has shown that harm reduction services such as medication-assisted
treatment, needle exchange, and safer injection facilities improve the health of
drug users without increasing drug use. Yet in many countries, policymakers and
the public wrongly believe that offering harm reduction services encourages
crime. Numerous studies by international organizations, national governments,
and public health institutions around the world have shown that harm reduction
neither increases crime nor erodes public order. Indeed, harm reduction in the
form of medication-assisted treatment has been shown to decrease criminal 
activities by illicit drug users. 
Medication-assisted Treatment 
Medication-assisted treatment—one of the best studied and
most effective forms of treatment for opiate dependence—
uses prescription medicines such as methadone or
buprenorphine to reduce injecting drug use by preventing
cravings for street opiates like heroin.1 In addition to
reducing HIV transmission and other injection-related
health problems,2,3 medication-assisted treatment (also
known as methadone maintenance treatment, substitution
treatment, or substitution therapy) helps with social
rehabilitation and reduces criminal activity.4
E V I D E N C E : International
• A 2004 paper by the World Health Organization 
(WHO), the United Nations Office on Drugs and Crime
(UNODC), and the United Nations Joint Programme on
HIV/AIDS (UNAIDS) noted that “Substitution mainte-
nance therapy can decrease the high cost of opioid
dependence to individuals, their families and society at
large by reducing heroin use, associated deaths, HIV risk
behaviours and criminal activity.”5
• According to WHO, UNODC, and UNAIDS, each dollar
invested in opioid dependence treatment programs can
yield savings of between $4 and $7 by reducing drug-
related crime and criminal justice costs. When savings
related to health care are included, total savings can
exceed costs by a ratio of 12 to 1.6
E V I D E N C E : United States
• In 1989, the Treatment Outcome Perspective Study, 
a landmark evaluation of chemical dependence
treatment in the United States, found that 32 percent
of patients entering methadone maintenance 
treatment acknowledged committing one or more
predatory crimes in the preceding year. Three to five
years after leaving treatment, only 16 percent of
patients reported such criminal activity, a 50 percent
reduction.7
• A 1991 study in Baltimore, Philadelphia, and New York
City showed that methadone programs in these cities
corresponded with a 71 percent decline in crimes
committed by participants. Patients in treatment for six
years or more had the lowest incidence of crime.8
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• A 2000 California study comparing medication-assisted
treatment to detoxification and psychosocial therapy
determined that methadone clients stayed in treatment
twice as long those receiving the other therapies.
Methadone patients also had lower rates of heroin use,
fewer drug-related HIV risk behaviors, and nearly a 
66 percent reduction in problems with the law.9
• A 2005 analysis of an alternative-sentencing policy for
non-violent drug-offenders in California found that in the
30 months following entry into the program, opiate users
in medication-assisted treatment had fewer felony or
misdemeanor arrests than opiate users in other drug
treatment programs.10
E V I D E N C E : Developing Countries
• Prior to enrolling in a methadone program, more than
half of the patients in a drug treatment program in
Bishkek, Kyrgyzstan, had criminal convictions. After one
year of methadone maintenance, only 3 of 50 patients 
had new criminal convictions.11
• A 2007 evaluation of a two-year-old Albanian methadone
program reported a decrease in criminal behaviors or
disputes with the police in 95 percent of patients who had
a history of legal problems.12
• A 2003 pilot methadone program in Malaysia reported
that nearly two thirds (61 percent) of its patients said their
employment situation had improved and that they had
not engaged in crime or high-risk behaviors since starting
methadone maintenance.13
• Preliminary results from a 2005 WHO assessment 
of methadone programs found that in Indonesia, 
patients’ criminal activity dropped from 37 percent to
12 percent after six months of treatment. In Thailand,
reports of criminal activity by methadone patients 
fell from 7 percent of patients to 2 percent in six 
months.14
• Self-reported rates of criminal behavior for clients in
China’s eight pilot methadone programs fell from 
21 percent of clients at intake to 4 percent of clients 
after 12 months.15
E V I D E N C E : Australia
• An analysis of the criminal records of more than 11,000
methadone clients by officials in New South Wales
revealed that for every 100 people in the methadone
program for one year, New South Wales experienced 
12 fewer robberies, 57 fewer burglaries, and 56 fewer
motor vehicle thefts.16
Syringe Exchange and 
Safer Injection Facilities
Needle and syringe programs, which provide sterile
injection equipment to injecting drug users, are a
cornerstone of harm reduction services. Numerous
studies show that these programs reduce HIV transmis-
sion without encouraging drug use or criminal activity,
and that they offer a bridge to additional health or
treatment services.17,18 Safer injection facilities where drug
users are medically supervised reduce overdoses and
health complications from injections and provide a route
to further treatment without increasing criminal activity
or public disorder.
E V I D E N C E : Worldwide
• In 2006, the Institute of Medicine, part of the U.S.
National Academy of Science, reviewed dozens of studies
in developed and developing countries and found no
evidence that needle and syringe programs increased the
number of publicly discarded needles or led to any
increases in crime.19 The analysis also noted that HIV
prevention programs that included needle and syringe
programs were associated with reductions in frequency of
injection, needle sharing, and other HIV risk behaviors.
• A 2004 study of North America’s first safer injection site,
which opened in Vancouver in 2003, examined crime
rates around the facility one year before and one year after
the site’s opening. The study found improvements in
several measures of public order, including a reduction in
the number of drug users injecting in public and used
syringes on the streets and sidewalks.20
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Research and experience show that medication-assisted treatment and needle exchange are  life-
saving measures that do not increase crime or public disturbances. Medication-assisted treatment
improves public safety by reducing the illicit drug dependence that can lead to theft and other
crimes. Harm reduction programs are an effective, practical, and humane way of improving the
health of both drug users and communities.
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